2024 CBIIC in Guangzhou on November 30 - December 2, 2024.

WANG Lei

Leon Wang is Executive Vice President, International and China President at AstraZeneca. He is responsible for the overall strategy for the region and for driving sustainable growth across our activities in China, Asia Area, Australia, New Zealand, as well as Latin America, Brazil, Russia, Eurasia, the Middle East and Africa. As a member of AstraZeneca’s Senior Executive Team, Leon reports to the CEO, Pascal Soriot.

Leon joined AstraZeneca China in March 2013 as Vice President for GI, Respiratory, Anaesthesia and Anti-infection (GRA), and was promoted to President of AstraZeneca China in 2014. Under Leon’s leadership, China has become AstraZeneca’s second-largest market worldwide, and AstraZeneca has become one of the fastest-growing multinational pharmaceutical companies in China. In January 2017, Leon was promoted to Executive Vice President, Asia Pacific Region at AstraZeneca, with responsibility for the strategy and sustainable growth of businesses in China, Asia Area, Australia and New Zealand. In May 2017, Leon further expanded his role to cover the whole international region as Executive Vice President.